$102.86
1.831.81%
At close: -
$102.86
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Addus HomeCare Analyst Ratings and Price Targets | NASDAQ:ADUS | Benzinga
Addus HomeCare Corp has a consensus price target of $132.2 based on the ratings of 16 analysts. The high is $150 issued by JMP Securities on April 22, 2025. The low is $83 issued by Barclays on April 23, 2024. The 3 most-recent analyst ratings were released by JMP Securities, JMP Securities, and Stephens & Co. on April 22, 2025, April 10, 2025, and March 12, 2025, respectively. With an average price target of $147.33 between JMP Securities, JMP Securities, and Stephens & Co., there's an implied 43.24% upside for Addus HomeCare Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JMP Securities
JMP Securities
Stephens & Co.
Macquarie
Stephens & Co.
1calculated from analyst ratings
Analyst Ratings for Addus HomeCare
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/22/2025 | Buy Now | 45.83% | JMP Securities | Nicholas Jones79% | $150 → $150 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/10/2025 | Buy Now | 45.83% | JMP Securities | Constantine Davides38% | $150 → $150 | Maintains | Market Outperform | Get Alert |
| 03/12/2025 | Buy Now | 38.05% | Stephens & Co. | Scott Fidel 43% | $142 → $142 | Reiterates | Overweight → Overweight | Get Alert |
| 02/27/2025 | Buy Now | 25.41% | Macquarie | Tao Qiu43% | $129 → $129 | Maintains | Outperform | Get Alert |
| 02/26/2025 | Buy Now | 38.05% | Stephens & Co. | Raj Kumar 49% | $153 → $142 | Maintains | Overweight | Get Alert |
| 01/24/2025 | Buy Now | 45.83% | Oppenheimer | Ari Wald53% | $145 → $150 | Maintains | Outperform | Get Alert |
| 12/16/2024 | Buy Now | 45.83% | JMP Securities | Constantine Davides38% | → $150 | Initiates | → Market Outperform | Get Alert |
| 11/14/2024 | Buy Now | 32.22% | RBC Capital | Ben Hendrix59% | $136 → $136 | Reiterates | Outperform → Outperform | Get Alert |
| 11/06/2024 | Buy Now | 40.97% | Stephens & Co. | Scott Fidel70% | $143 → $145 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | 32.22% | RBC Capital | Ben Hendrix59% | $141 → $136 | Maintains | Outperform | Get Alert |
| 11/04/2024 | Buy Now | 35.14% | Macquarie | Tao Qiu43% | $139 → $139 | Maintains | Outperform | Get Alert |
| 10/11/2024 | Buy Now | 35.14% | Macquarie | Tao Qiu43% | $139 → $139 | Maintains | Outperform | Get Alert |
| 10/11/2024 | Buy Now | 45.83% | Keybanc | Matthew Gillmor65% | → $150 | Initiates | → Overweight | Get Alert |
| 09/23/2024 | Buy Now | 40.97% | Oppenheimer | Michael Wiederhorn61% | $140 → $145 | Maintains | Outperform | Get Alert |
| 09/03/2024 | Buy Now | 37.08% | RBC Capital | Ben Hendrix59% | $141 → $141 | Reiterates | Outperform → Outperform | Get Alert |
| 08/08/2024 | Buy Now | 37.08% | RBC Capital | Ben Hendrix59% | $129 → $141 | Maintains | Outperform | Get Alert |
| 08/08/2024 | Buy Now | 33.19% | TD Cowen | Ryan Langston23% | $128 → $137 | Maintains | Buy | Get Alert |
| 08/07/2024 | Buy Now | 39.02% | Stephens & Co. | Scott Fidel70% | $138 → $143 | Maintains | Overweight | Get Alert |
| 08/07/2024 | Buy Now | 36.11% | Oppenheimer | Michael Wiederhorn61% | $130 → $140 | Maintains | Outperform | Get Alert |
| 08/06/2024 | Buy Now | 34.16% | Stephens & Co. | Scott Fidel70% | $138 → $138 | Reiterates | Overweight → Overweight | Get Alert |
| 06/28/2024 | Buy Now | 32.22% | Macquarie | Tao Qiu43% | → $136 | Initiates | → Outperform | Get Alert |
| 06/18/2024 | Buy Now | 24.44% | TD Cowen | Ryan Langston23% | $119 → $128 | Maintains | Buy | Get Alert |
| 06/07/2024 | Buy Now | 26.39% | Oppenheimer | Michael Wiederhorn61% | $118 → $130 | Maintains | Outperform | Get Alert |
| 05/31/2024 | Buy Now | 24.44% | Stephens & Co. | Scott Fidel70% | $120 → $128 | Maintains | Overweight | Get Alert |
| 05/09/2024 | Buy Now | 15.69% | TD Cowen | Ryan Langston23% | $105 → $119 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | 11.8% | Stephens & Co. | Scott Fidel70% | → $115 | Reiterates | Overweight → Overweight | Get Alert |
| 05/07/2024 | Buy Now | 14.72% | B of A Securities | Joanna Gajuk65% | $115 → $118 | Maintains | Buy | Get Alert |
| 04/23/2024 | Buy Now | -19.31% | Barclays | Andrew Mok54% | $88 → $83 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 03/26/2024 | Buy Now | 14.72% | Oppenheimer | Michael Wiederhorn61% | $118 → $118 | Maintains | Outperform | Get Alert |
| 03/06/2024 | Buy Now | -14.45% | Barclays | Andrew Mok54% | → $88 | Initiates | → Equal-Weight | Get Alert |
| 02/29/2024 | Buy Now | -0.84% | RBC Capital | Ben Hendrix59% | $102 → $102 | Reiterates | Outperform → Outperform | Get Alert |
| 02/05/2024 | Buy Now | — | William Blair | Jared Haase69% | — | Assumes | → Outperform | Get Alert |
| 01/17/2024 | Buy Now | 14.72% | Oppenheimer | Michael Wiederhorn61% | → $118 | Reiterates | Outperform → Outperform | Get Alert |
| 12/12/2023 | Buy Now | 2.08% | TD Cowen | Ryan Langston23% | → $105 | Initiates | → Outperform | Get Alert |
| 11/01/2023 | Buy Now | -0.84% | RBC Capital | Ben Hendrix59% | $109 → $102 | Maintains | Outperform | Get Alert |
| 11/01/2023 | Buy Now | 2.08% | Stephens & Co. | Scott Fidel70% | $110 → $105 | Maintains | Overweight | Get Alert |
| 08/02/2023 | Buy Now | 14.72% | Oppenheimer | Michael Wiederhorn61% | → $118 | Reiterates | Outperform → Outperform | Get Alert |
| 08/02/2023 | Buy Now | 2.08% | Raymond James | John Ransom76% | $100 → $105 | Maintains | Outperform | Get Alert |
| 08/02/2023 | Buy Now | 6.94% | Stephens & Co. | Scott Fidel70% | $100 → $110 | Maintains | Overweight | Get Alert |
| 08/01/2023 | Buy Now | -2.78% | Stephens & Co. | Scott Fidel70% | → $100 | Reiterates | Overweight → Overweight | Get Alert |
| 06/29/2023 | Buy Now | 14.72% | Oppenheimer | Michael Wiederhorn61% | $118 → $118 | Reiterates | Outperform → Outperform | Get Alert |
| 05/26/2023 | Buy Now | 14.72% | Oppenheimer | Michael Wiederhorn61% | → $118 | Reiterates | Outperform → Outperform | Get Alert |
| 05/05/2023 | Buy Now | -2.78% | Raymond James | John Ransom76% | $125 → $100 | Maintains | Outperform | Get Alert |
| 05/03/2023 | Buy Now | 5.97% | RBC Capital | Ben Hendrix59% | $123 → $109 | Maintains | Outperform | Get Alert |
| 05/03/2023 | Buy Now | 14.72% | Oppenheimer | Michael Wiederhorn61% | $130 → $118 | Maintains | Outperform | Get Alert |
| 05/02/2023 | Buy Now | 19.58% | Stephens & Co. | Scott Fidel70% | → $123 | Reiterates | → Overweight | Get Alert |
| 04/05/2023 | Buy Now | 19.58% | Stephens & Co. | Scott Fidel70% | → $123 | Reiterates | → Overweight | Get Alert |
| 03/06/2023 | Buy Now | 19.58% | RBC Capital | Ben Hendrix59% | $121 → $123 | Maintains | Outperform | Get Alert |
| 11/02/2022 | Buy Now | 17.64% | RBC Capital | Ben Hendrix59% | $110 → $121 | Maintains | Outperform | Get Alert |
| 11/02/2022 | Buy Now | 21.52% | Raymond James | John Ransom76% | $115 → $125 | Maintains | Outperform | Get Alert |
| 08/03/2022 | Buy Now | 6.94% | RBC Capital | Ben Hendrix59% | $111 → $110 | Maintains | Outperform | Get Alert |
| 08/03/2022 | Buy Now | 26.39% | Oppenheimer | Michael Wiederhorn61% | $135 → $130 | Maintains | Outperform | Get Alert |
| 06/29/2022 | Buy Now | -1.81% | Stifel | Tao Qiu43% | → $101 | Initiates | → Buy | Get Alert |
| 06/21/2022 | Buy Now | -1.81% | Stephens & Co. | Scott Fidel70% | $110 → $101 | Maintains | Overweight | Get Alert |
| 05/04/2022 | Buy Now | 7.91% | RBC Capital | Ben Hendrix59% | $125 → $111 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Addus HomeCare (ADUS) stock?
The latest price target for Addus HomeCare (NASDAQ:ADUS) was reported by JMP Securities on April 22, 2025. The analyst firm set a price target for $150.00 expecting ADUS to rise to within 12 months (a possible 45.83% upside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Addus HomeCare (ADUS)?
The latest analyst rating for Addus HomeCare (NASDAQ:ADUS) was provided by JMP Securities, and Addus HomeCare reiterated their market outperform rating.
When was the last upgrade for Addus HomeCare (ADUS)?
There is no last upgrade for Addus HomeCare
When was the last downgrade for Addus HomeCare (ADUS)?
The last downgrade for Addus HomeCare Corp happened on April 23, 2024 when Barclays changed their price target from $88 to $83 for Addus HomeCare Corp.
When is the next analyst rating going to be posted or updated for Addus HomeCare (ADUS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Addus HomeCare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Addus HomeCare was filed on April 22, 2025 so you should expect the next rating to be made available sometime around April 22, 2026.
Is the Analyst Rating Addus HomeCare (ADUS) correct?
While ratings are subjective and will change, the latest Addus HomeCare (ADUS) rating was a reiterated with a price target of $150.00 to $150.00. The current price Addus HomeCare (ADUS) is trading at is $102.86, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
